Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The plasma membrane of Leishmania parasites is a complex assembly of phospholipids and unique 24-alkylated sterols, such as ergosterol and 5-dehydroepisterol, which are distinct from the cholesterol found in mammalian membranes (Goad et al., 1984). These lipids are essential for maintaining membrane integrity, fluidity, and the function of membrane-bound proteins required for the parasite's survival and infectivity (Roberts et al., 2003). Because of these biochemical differences, the membrane lipids serve as critical targets for anti-leishmanial drugs (Croft et al., 2006). Amphotericin B, a polyene macrolide, binds with high affinity to 24-alkylated sterols, leading to the formation of aqueous pores that cause the leakage of essential ions and subsequent cell death (Baginski and Czub, 2009). Miltefosine, an alkylphosphocholine, targets the phospholipid metabolism and disrupts intracellular signaling pathways, further compromising the parasite's membrane stability (Dorlo et al., 2012). The specificity of these interactions allows for the selective targeting of the parasite over the host, although the development of resistance and the inherent toxicity of some agents remain significant clinical challenges.
Polyene antibiotics like Amphotericin B bind directly to 24-alkylated sterols (ergosterol-like) to form trans-membrane pores, leading to ion leakage and osmotic lysis; alkylphosphocholines like Miltefosine interfere with phospholipid metabolism and cell signaling pathways.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leishmania plasma membrane phospholipids and 24-alkylated sterols.